Treatment of moderate to severe hidradenitis suppurativa.
Kimball, Alexa B, Yihua Gu, and Martin Okun. 2013. “Treatment of Moderate to Severe Hidradenitis Suppurativa.”. Annals of Internal Medicine 159 (1): 72-3.
Search
Search results
399 results found
Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study.
Kimball, Alexa B, Dimittri Delevry, Min Yang, Chien-Chia Chuang, Zhixiao Wang, Gaëlle Bégo-Le-Bagousse, Bruno Martins, et al. 2023. “Long-Term Effectiveness of Dupilumab in Patients With Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study.”. Dermatology and Therapy 13 (9): 2107-20.
BIDMC’s Alexa Kimball, MD, MPH receives Lifetime Achievement Award from the National Psoriasis Foundation
Discussing New Phase 2 Findings on Lutikizumab for Hidradenitis Suppurativa with Alexa Kimball, MD, MPH
Alexa Kimball, MD, MPH: Latest Trial Data on Secukinumab for Hidradenitis Suppurativa
Leading a physicians group through COVID-19 challenges: 6 questions with Harvard's Dr. Alexa Kimball
Facing down financial shortfalls, Harvard Medical Faculty Physicians' Alexa Kimball launches major practice into telehealth
More Resources
Meta-analysis comparing efficacy of antibiotics versus oral contraceptives in acne vulgaris.
Koo, Eubee Baughn, Tyler Daniel Petersen, and Alexandra Boer Kimball. 2014. “Meta-Analysis Comparing Efficacy of Antibiotics versus Oral Contraceptives in Acne Vulgaris.”. Journal of the American Academy of Dermatology 71 (3): 450-9.